GLP-3 RT 10mg Peptides
Designed for researchers who value precision and consistency, this GLP-3 RT vial delivers dependable performance for disciplined laboratory workflows.
This lyophilized peptide vial features GLP-3 RT in a stable, dry format with a total content of 10mg. The solid-state presentation supports controlled reconstitution to protocol-specific concentrations, enabling accurate dosing, repeatable methods, and efficient aliquoting for ongoing study designs. Built for professional settings, it’s an exacting option for investigators who prioritize reliability over guesswork.
- Each vial contains 10mg of GLP-3 RT, supporting receptor pathway exploration, structure–activity investigations, and other non-clinical applications where clarity, control, and consistency are essential.
As a non-edible laboratory reagent, this lyophilized peptide is engineered for straightforward handling. The dry, uniform cake is formulated to dissolve cleanly in a suitable sterile diluent when reconstituted according to your lab’s SOPs, helping reduce variability across preparations. The format is well-suited for measured transfers, minimizing waste and facilitating precise concentration targeting for in vitro or ex vivo work.
Researchers can expect a streamlined bench experience: predictable dissolution, clear labeling for rapid identification, and packaging configured to protect integrity through typical lab handling and storage practices. Whether you are establishing baseline data, comparing analogs, or validating methods, the form factor and consistency of this vial are designed to support confident, repeatable results.
Quality and trust, built into every lot: Produced to rigorous laboratory standards in the USA, each batch undergoes analytical verification for identity and purity using established methods such as HPLC and mass spectrometry. Lot-level traceability and documentation are maintained to support internal QA requirements. Peptide Scientific Labs prioritizes careful handling, clear specification control, and transparent labeling so you can focus on the science with confidence.
For laboratory research use only. Not for human consumption, injection, clinical, or veterinary use. Handle only by qualified professionals in appropriately equipped facilities and follow all applicable regulations, safety protocols, and institutional guidelines.
We prioritize your satisfaction above all, which is why we offer a 100-day, no-questions-asked guarantee on all our products. Learn more about our return policy.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.